Physician-prescribed. USA-Compounded. Delivered to your door.
Entry-level GLP-1
The ideal starting point. Lower dose, fewer side effects, full clinical support.
Provider review within 24 hours
GLP-1 Receptor Agonist
Regulates appetite and fullness. Strong clinical track record for sustained weight loss.
Provider review within 24 hours
GLP-1 / GIP Dual Agonist
Dual-pathway protocol. Higher average weight loss in clinical trials. Provider-determined.
Provider review within 24 hours
Cellular Longevity
Cellular energy and metabolism support. Pairs well with GLP-1 protocols.
Provider review within 24 hours
"I wasn't looking for a shortcut. I wanted something that actually worked with my body. Three months in, down 24 lbs — and I have more energy than I did at 32."
Doctor of Nursing Practice · Licensed Provider, Foundry RX
Specializes in metabolic health and GLP-1 protocols. Every Foundry protocol is reviewed by a licensed US provider — not an algorithm.
NPI: 1144870056 · Protocol reviewed May 2026 · LegitScript Certified
Physician consultation, personalized protocol, dose titration, unlimited follow-up, and discreet US shipping. Semaglutide $169/mo. Tirzepatide $239/mo. No hidden fees.
Semaglutide targets the GLP-1 receptor. Tirzepatide targets both GLP-1 and GIP — a dual mechanism that showed higher average weight reduction in trials for some patients. Your provider recommends the right one.
Compounded semaglutide and tirzepatide are not FDA-approved finished drug products. They are prepared by licensed 503B outsourcing facilities and prescribed at the clinical judgment of a licensed physician.
US-made at 503B-certified outsourcing facilities, batch-tested above 99.9% purity. We do not source from overseas compounders.
Clinical trials showed ~15% average reduction with semaglutide and up to 22% with tirzepatide over 68 weeks with lifestyle changes. Individual results vary.
All 50 states through our licensed telehealth network. Medication ships directly to your door.
NAD+ supports cellular energy, DNA repair, and metabolism. It's often paired with GLP-1 programs to reduce fatigue during caloric restriction. Your provider determines if it's appropriate for your protocol.
GLP-1 receptor agonists including compounded semaglutide and tirzepatide may have serious side effects, including possible thyroid tumors. Do not use if you or your family have a history of medullary thyroid carcinoma (MTC) or MEN 2. Compounded medications are not FDA-approved drugs. All medications prescribed at independent clinical judgment of licensed physicians. Common side effects include nausea, diarrhea, vomiting, and constipation. Membership does not include medication cost. Individual results vary. Not available in all states.
19 pages. Everything the industry won't put in plain language — written for people who want clinical-grade answers without the jargon.
Complete your intake today. If GLP-1 treatment is appropriate, your provider will build a plan around your body, goals, and tolerance.